TickerLeague

Buyback Spend for Charles River (CRL)

Buyback Spend for Charles River (CRL): headline value $360.67M · YoY +202.6%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Latest period

$360.67M

YoY change

+202.6%

5Y CAGR

+72.0%

Peak year (2025)

$360.67M

Latest annual

$360.67M

Buyback Spend history chart for Charles River (CRL) from 1998 to 2025

Buyback Spend history table for Charles River (CRL) from 1998 to 2025

Fiscal yearPeriod endedReportedBuyback SpendYoY
2025$360.67M+202.6%
2024$119.17M+393.4%
2023$24.16M-37.5%
2022$38.65M-5.1%
2021$40.71M+69.8%
2020$23.98M+32.6%
2019$18.09M+30.6%
2018$13.85M-87.0%
2017$106.91M+771.5%
2016$12.27M-89.6%
2015$117.48M-3.7%
2014$122.02M-26.5%
2013$165.93M+158.5%
2012$64.19M-77.4%
2011$283.80M-20.4%
2010$356.53M+676.8%
2009$45.90M-60.1%
2008$115.06M+176.5%
2007$41.62M-83.4%
2006$249.96M+1288.9%
2005$18.00M
2004$0
2003$0
2002$0
2001$0
2000$0
1999$0
1998$0

Buyback Spend values are taken from Charles River's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

2025's annual buyback spend for Charles River (CRL) came in at $360.67M – surged 202.6% year-over-year.

Charles River buyback spend compound annual growth for the 2020–2025 (5 years) window is +72.0%, sustaining 2 straight years of year-over-year growth.

The dataset's maximum buyback spend sits at $360.67M (2025); the minimum reading of $0 dates to 1998.

Within Healthcare, Charles River (CRL) ranks 8th among 8 peers we track. The peer median for buyback spend is $2.75B.

Charles River Buyback Spend by Year

Charles River Buyback Spend 2025: $360.67M

Charles River buyback spend in 2025 was $360.67M, surged 202.6% from 2024. This figure represents the highest annual value in the available history.

Charles River Buyback Spend 2024: $119.17M

Charles River buyback spend in 2024 was $119.17M, surged 393.4% from 2023.

Charles River Buyback Spend 2023: $24.16M

Charles River buyback spend in 2023 was $24.16M, plunged 37.5% below 2022.

Charles River Buyback Spend 2022: $38.65M

Charles River buyback spend in 2022 was $38.65M, declined 5.1% below 2021.

Charles River Buyback Spend 2021: $40.71M

Charles River buyback spend in 2021 was $40.71M.

See more financial history for Charles River (CRL).

Sector peers — Buyback Spend

Companies in the same sector as Charles River, ranked by their latest buyback spend.

CompanyBuyback SpendSector
Johnson & Johnson (JNJ)$5.95BHealthcare
UnitedHealth Group Incorporated (UNH)$5.54BHealthcare
Merck & Co., Inc. (MRK)$5.08BHealthcare
Eli Lilly and Company (LLY)$4.11BHealthcare
Novo Nordisk A/S (NVO)$1.39BHealthcare
AbbVie Inc. (ABBV)$980.00MHealthcare
AstraZeneca PLC (AZN)$719.66MHealthcare
Amgen Inc. (AMGN)$0Healthcare

Frequently asked questions

What is Charles River's buyback spend?

Latest reported buyback spend for Charles River (CRL) is $360.67M (period ending December 27, 2025).

How has Charles River buyback spend changed year-over-year?

Charles River (CRL) buyback spend changed +202.6% year-over-year on the latest annual filing.

What is the long-term growth rate of Charles River buyback spend?

Charles River (CRL) buyback spend compound annual growth rate is +72.0% over the most recent 5 years available.

When did Charles River buyback spend hit its highest annual value?

Charles River buyback spend reached its highest annual value of $360.67M in 2025.

What was Charles River buyback spend in 2024?

Charles River (CRL) buyback spend in 2024 was $119.17M.

What was Charles River buyback spend in 2025?

Charles River (CRL) buyback spend in 2025 was $360.67M.

Metrics overview

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.